MichaelPaulLinkMD

PubMed

• 3 citations
  Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling.
  Jin, M., Stefan K Alig, Mohammad Shahrokh Esfahani, Andrea Garofalo, Michael Yu Li, Cédric Rossi, Tim Flerlage, Jamie E Flerlage, Ragini Adams, Michael S Binkley, Navi...> ;Nature. 2024 Jan 1
• 438 citations
  The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
  Elias Campo, Elaine S Jaffe, James R Cook, Leticia Quintanilla-Martinez, Steven H Swerdlow, Kenneth C Anderson, Pierre Brousset, Lorenzo Cerroni, Laurence de Leval, St...> ;Blood. 2022 Sep 15
• 9 citations
  Diagnostic Accuracy of 2-[F]FDG-PET and whole-body DW-MRI for the detection of bone marrow metastases in children and young adults.
  Lucia Baratto, Ashok Joseph Theruvath, Elton Benjamin Greene, K Elizabeth Hawk, Rong Lu, Michael P Link, Sheri L Spunt, Heike E Daldrup-Link, Ali Rashidi> ;European Radiology. 2022 Jul 1
• 25 citations
  Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance.
  Carol Durno, Ayse Bahar Ercan, Vanessa Bianchi, Melissa Edwards, Melyssa Aronson, Melissa Galati, Eshetu G. Atenafu, Gadi Abebe-Campino, Abeer Al-Battashi, Musa Alharb...> ;Journal of Clinical Oncology. 2021 May 4
• 21 citations
  Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation
  Monika L. Metzger, Michael P. Link, Amy L. Billett, Jamie E. Flerlage, John T. Lucas, Belinda N. Mandrell, Matthew J. Ehrhardt, Nickhill Bhakta, Torunn I. Yock, Alison...> ;Journal of Clinical Oncology. 2021 Apr 7
• 3 citations
  Summary of COVID-19 clinical practice adjustments across select institutions.
  Liora M. Schultz, Michael P. Link, Susan R. Rheingold, Douglas S. Hawkins, Jeffrey S. Dome, Jonathan E. Wickiser, Andrew L. Kung, Tara O. Henderson, Catherine Aftandilian> ;Pediatric Blood & Cancer. 2020 Jul 19
• 24 citations
  Therapy Response Assessment of Pediatric Tumors with Whole-Body Diffusion-weighted MRI and FDG PET/MRI.
  Ashok J. Theruvath, Florian Siedek, Anne M. Muehe, Jordi Garcia-Diaz, Julian Kirchner, Ole Martin, Michael P. Link, Sheri L. Spunt, Allison Pribnow, Jarrett Rosenberg,...> ;Radiology. 2020 May 5
• 2 citations
  Minding the Gap for Survivors of Childhood Cancer.
  Stephanie M. Smith, Michael P. Link, Karen E. Effinger> ;JAMA Oncology. 2020 Mar 1
• 2 citations
  Treatment and outcomes in classic Hodgkin lymphoma post-transplant lymphoproliferative disorder in children.
  Clare J. Twist, Susan M. Hiniker, Dita Gratzinger, D.J. Merriott, Andrei Iagaru, Michael P. Link, Sarah S. Donaldson, Paulina M. Gutkin> ;Pediatric Blood & Cancer. 2019 Aug 1
• 185 citations
  Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
  Peter F. Coccia, Alberto S. Pappo, Lynda K. Beaupin, Virginia F. Borges, Scott C. Borinstein, Rashmi Chugh, Shira Dinner, Jeanelle Folbrecht, A. Lindsay Frazier, Rober...> ;Journal of the National Comprehensive Cancer Network. 2018 Jan 1
• 30 citations
  Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): Methodology statement.
  Jamie E. Flerlage, Kara M. Kelly, Auke Beishuizen, Steve Y. Cho, Pedro A. de Alarcon, Ute Dieckmann, Richard A. Drachtman, Bradford S. Hoppe, Scott C. Howard, Sue C. K...> ;Pediatric Blood & Cancer. 2017 Jul 1
• 22 citations
  Access to essential medicines for children with cancer: a joint SIOP-CCI position statement.
  Avram Denburg, Brijesh Arora, Ramandeep Singh Arora, Carmen Auste, Poonam Bagai, Ronald D. Barr, Julia Challinor, Tim O B Eden, Edith Grynzspancholc, Ruth I. Hoffman, ...> ;The Lancet. Oncology. 2017 Jan 1
• 28 citations
  A study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma.
  Michael G. Ozawa, Aparna Bhaduri, Karen M. Chisholm, Steven Andrew Baker, Lisa Ma, James L. Zehnder, Sandra Luna-Fineman, Michael P. Link, Jason D. Merker, Daniel A. A...> ;Modern Pathology. 2016 Jun 24
• 55 citations
  Safety Report of Ferumoxytol for Magnetic Resonance Imaging in Children and Young Adults.
  Anne M. Muehe, Dan Feng, Rie von Eyben, Sandra Luna-Fineman, Michael P. Link, Travis Muthig, Amy Huddleston, Edward A. Neuwelt, Heike E. Daldrup-Link> ;Investigative Radiology. 2016 Apr 1
• 4 citations
  For Patients With Cancer, Cure Is Not Enough
  Karen E. Effinger, Michael P. Link> ;JAMA Oncology. 2016 Feb 1
• 118 citations
  In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs
  Ayalew Tefferi, Hagop M. Kantarjian, S. Vincent Rajkumar, Larry Baker, J L Abkowitz, John W. Adamson, Ranjana H. Advani, James P. Allison, Karen H. Antman, Robert C. B...> ;Mayo Clinic Proceedings. 2015 Aug 1
• 12 citations
  Subcutaneous panniculitis-like T-cell lymphoma: Pediatric case series demonstrating heterogeneous presentation and option for watchful waiting.
  Emily E. Johnston, Robert E. LeBlanc, Jinah Kim, Jong Hee Chung, Jay Michael S. Balagtas, Youn H. Kim, Michael P. Link> ;Pediatric Blood & Cancer. 2015 Nov 1
• 2 citations
  Primary Cutaneous Gamma-Delta T-Cell Lymphoproliferative Disorder in a 3-Year-Old Boy.
  Christopher W. M. Soon, Michael P. Link, Youn H. Kim, Jinah Kim> ;The American Journal of Dermatopathology. 2015 Jul 1
• 9 citations
  Management of nodular lymphocyte predominant Hodgkin lymphoma in the modern era.
  Martin T. King, Sarah S. Donaldson, Michael P. Link, Yasodha Natkunam, Ranjana H. Advani, Richard T. Hoppe> ;International Journal of Radiation Oncology, Biology, Physics. 2015 May 1
• 2 citations
  The utility of IgM, CD21, HGAL and LMO2 in the diagnosis of pediatric follicular lymphoma.
  Tejashree Karnik, Michael G. Ozawa, Martina I. Lefterova, Sandra Luna-Fineman, Elysia Alvarez, Michael P. Link, James L. Zehnder, Daniel A. Arber, Robert S. Ohgami> ;Human Pathology. 2015 Apr 1
• 15 citations
  Improved Outcomes after Autologous Bone Marrow Transplantation for Children with Relapsed or Refractory Hodgkin Lymphoma: Twenty Years Experience at a Single Institution
  Phillip M. Garfin, Michael P. Link, Sarah S. Donaldson, Ranjana H. Advani, Sandra Luna-Fineman, Sandhya Kharbanda, Matthew H. Porteus, Kenneth I. Weinberg, Rajni Agarw...> ;Biology of Blood and Marrow Transplantation. 2015 Feb 1
• 67 citations
  Value of 18F-FDG PET and PET/CT for Evaluation of Pediatric Malignancies
  Lebriz Uslu, Jessica Donig, Michael P. Link, Jarrett Rosenberg, Andrew Quon, Heike E. Daldrup-Link> ;Journal of Nuclear Medicine. 2015 Feb 1
• 62 citations
  Milestones in the Curability of Pediatric Cancers
  Melissa M. Hudson, Michael P. Link, Joseph V. Simone> ;Journal of Clinical Oncology. 2014 Apr 14
• 20 citations
  Increased utilization of pediatric specialty care: a population study of pediatric oncology inpatients in California.
  Lisa J. Chamberlain, Noelle Pineda, Lena E. Winestone, Olga Saynina, Arun Rangaswami, Michael P. Link, Paul H. Wise> ;Journal of Pediatric Hematology/oncology. 2014 Mar 1
• 94 citations
  Adolescent and young adult oncology, version 2.2014: Featured updates to the NCCN guidelines
  , , , , , , , , , , , , , , , , , , , , , , , > ;Journal of the National Comprehensive Cancer Network. 2014 Jan 1
• Join now to see all

Journal Articles

• Milestones in the curability of pediatric cancers  
  Hudson MM, Link MP, Simone JV, J Clin Oncol, 1/1/2014
• Adolescent and young adult oncology, version 22014  
  Coccia PF, Pappo AS, Altman J, Bhatia S, Borinstein SC, Flynn J, Frazier L, George S, Goldsby R, Hayashi R, Huang MS, Johnson RH, Beaupin LK, Link MP, Oeffinger KC, Or..., J Natl, Compr Canc Netw, 1/1/2014
• Increased utilization of pediatric subspecialty care: A population study of pediatric oncology inpatients in California  
  Chamberlain LJ, Pineda N, Winestone L, Saynina O, Rangaswami A, Link M, Wise PH, J Pediatr Hematol Oncol, 1/1/2014
• Collaborating to Conquer Cancer: Lessons from Our Children  
  Link MP, J Clin Oncol, 1/1/2013
• Relapse after treatment of pediatric Hodgkin lymphoma: Outcome and role of surveillance after end of therapy  
  Friedmann AM, Wolfson JA, Hudson MM, Weinstein HJ, Link MP, Billett A, Larson EC, Yock T, Donaldson SS, Marcus K, Krasin MJ, Howard SC, Metzger ML, Pediatr Blood Cancer, 1/1/2013
• Exteremely low-frequency magnetic fields and survival from childhood acute lymphoblastic leukemia: An international follow up study  
  Schüz J, Grell K, Kinsey S, Linet MS, Link MP, Mezei G, Pollock BH, Roman E, Zhang Y, McBride ML, Johansen C, Spix C, Hagihara J, Saito AM, Simpson J, Robison LL, Dock..., Blood Cancer Journal, 1/1/2012
• Chemotherapy drug shortages in the United States: Genesis and potential solutions  
  Link MP, Hagerty K, Kantarjian HM, J Clin Oncol, 1/1/2012
• Adolescent and young adult oncology Clinical practice guidelinies in oncology  
  Coccia PF, Altman J, Bhatia S, Borinstein SC, Flynn J, George S, Goldsby R, Hayashi R, Huang MS, Johnson RH, Beaupin LK, Link MP, Oeffinger KC, Orr KM, Pappo AS, Reed ..., J Natl, Compr Canc Netw, 1/1/2012
• Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable risk Hodgkin lymphoma  
  Metzger ML, Weinstein HJ, Hudson MM, Billett AL, Larsen EC, Friedmann A, Howard SC, Donaldson SS, Krasin MJ, Kun LE, Marcus KJ, Yock TI, Tarbell N, Billups CA, Wu J, L..., JAMA, 1/1/2012
• ALK+ anaplastic large cell lymphoma exhibits phosphatidylinositol-3 kinase/Akt activity with retained by inactivated PTEN—A report from the Children’s Oncology Group  
  Thakral C, Hutchison RE, Shrimpton A, Barrett D, Laver J, Link M, Halleran DR, Hudson S, Pediatr Blood Cancer, 1/1/2012
• Complete ocular paresis in a child with posterior fossa syndrome  
  Afshar M, Link M, Edwards MSB, Fisher PG, Fredrick D, Monje M, Pediatr Neurosurg, 1/1/2012
• Second malignant neoplasms in survivors of pediatric Hodgkin’s lymphoma treated with low-dose radiation and chemotherapy  
  O’Brien MM, Donaldson SS, Balise RR, Whittemore AS and Link MP, J Clin Oncol, 1/1/2010
• The impact of the Privacy Rule on cancer research: Variations in attitudes and application of regulatory standards  
  Goss E, Link M, Bruinooge SS, Lawrence TS, Tepper J, Runowicz C, Schilsky RL, J Clin Oncol, 1/1/2009
• Nodular lymphocyte predominant Hodgkin lymphoma presenting as fulminant hepatic failure in a pediatric patient: A case report with pathologic, immunophenotypic and mo...  
  Woolf KMW, Wei MC, Link MP, Arber DA, Warnke RA, Appl Immunohistochem Mol Morphol, 1/1/2008
• Osteosarcoma: The addition of muramyl tripeptide to chemotherapy improves overall survival--A report from the Children’s Oncology Group  
  Meyers PA, Schwartz CL, Krailo MD, Healey JH, Bernstein ML, Betcher D, Ferguson WS, Gebhardt MC, Goorin AM, Harris M, Kleinerman E, Link, MP, Nadel H, Nieder M, Siegal..., J Clin Oncol, 1/1/2008
• Non-anaplastic peripheral T-cell lymphoma in childhood and adolescence: A Children’s Oncology Group Study  
  Hutchison RE, Laver JH, Chang M, Muzzafar T, Desai S, Murphy S, Schwenn M, Shuster J, Link MP, Pediatr Blood Cancer, 1/1/2008
• Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: a report from the Children’s Oncology Group  
  Bhatia S, Krailo MD, Chen Z, Burden L, Askin FB, Dickman PS, Grier HE, Link MP, Meyers PA, Perlman EJ, Rausen AR, Robison LL, Vietti TJ, Miser JS, Blood, 1/1/2007
• Final results of a prospective clinical trial with VAMP and low-dose involved field radiation for children with low-risk Hodgkin’s disease  
  Donaldson SS, Link MP, Weinstein HJ, Rai SN, Brain S, Billett AL, Hurwitz CA, Krasin M, Kun LE, Marcus KC, Tarbell NJ, Young JA, Hudson MM, J Clin Oncol, 1/1/2007
• Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: Evaluation of increasing the dose intensity of chemotherapy—A report from the Children’...  
  Miser JS, Goldsby RE, Chen Z, Krailo MD, Tarbell NJ, Link MP, Fryer CJH, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore SG, Rausen A..., Pediatr Blood Cancer, 1/1/2007
• Magnetic field exposure and long-term survival among children with leukaemia  
  Foliart DE, Pollock BH, Mezei G, Iriye R, Silva JM, Ebi KL, Kheifets L, Link MP, Kavet R, Br J Cancer, 1/1/2006
• Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group phase II study 9457--A report from the Ch...  
  Bernstein ML, Devidas M, Lafreniere D, Souid A-K, Meyers PA, Gebhardt M, Stine K, Nicholas R, Perlman EJ, Dubowy R, Wainer IW, Dickman PS, Link MP, Goorin A, Grier HE, J Clin Oncol, 1/1/2006
• Osteosarcoma: A randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high dose methotrexate  
  Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W, Gebhardt M, Goorin AM, Harris MB, Healey J, Huvos A, Link M, Montebello..., J Clin Oncol, 1/1/2005
• Epstein-Barr virus-associated peripheral T-cell lymphoma and hemophagocytic syndrome arising after liver transplantation: Case report and review of the literature  
  George TI, Jeng M, Berquist W, Cherry AM, Link MP, Arber DA, Pediatr Blood Cancer, 1/1/2005
• Review of tonsillar lymphoma in pediatric patients from the Pediatric Oncology Group: What can be learned about some indications for microscopic examination?  
  Sayed K, Savell VH, Hutchison RE, Kepner J, Link MP, Schwenn M, Mahmoud H, Parham DM, Pediatr Dev Pathol, 1/1/2005
• Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: A report fro...  
  Spunt SL, Smith LM, Ruymann FB, Qualman SJ, Donaldson SS, Rodeberg DA, Anderson JR, Crist WM, Link MP, Clinical Cancer Research, 1/1/2004
• Join now to see all

Books/Book Chapters

• Pediatric Lymphomas. 
  Editors: HJ Weinstein, MM Hudson and MP Link.Springer-Verlag, Berlin2007
• Principles and Practice of Pediatric Oncology. 
  Chapter: Malignant Non-Hodgkin Lymphomas in Children. 
  Page 722 - 747Link MP and Weinstein HJEditors: P Pizzo and D Poplack.Lippincott Williams & Wilkins, Philadelphia, PAEdition 5th,2006
• Hematology: Basic Principles and Practice. 
  Chapter: Malignant lymphomas in childhood. 
  Page 1421 - 1435Sandlund JT and Link MPEditors: R Hoffman, EJ Benz, SJ Shattil, B Furie, HJ Cohen, LE Silberstein, and P McGlave.Elsevier Churchill Livingstone, Philadelphia, PA2005
• Assessment of lymphadenopathy in children. 
  Twist CJ and Link MP2002
• Frontiers of osteosarcoma research: Interdisciplinary survey of clinical and research advances. 
  Chapter: Preoperative and adjuvant chemotherapy in osteosarcoma. 
  Page 41 - 49Link MPEditors: JF Novak and JH McMaster.Hogrefe and Huber, Seattle, WA1993
• Osteosarcoma In Adolescents And Young Adults: New Developments And Controversies. 
  Chapter: The Multi-institutional osteosarcoma study: An update. 
  Page 261 - 267Link MPEditors: GB. Humphrey, HS Koops, WM Molenaar, and A Postma.Kluwer Academic Publishers, Boston, MA1993
• Osteosarcoma In Adolescents And Young Adults: New Developments And Controversies. 
  Chapter: Commentary on the use of presurgical chemotherapy. 
  Page 383 - 385Link MPEditors: GB. Humphrey, HS Koops, WM Molenaar, and A Postma.Kluwer Academic Publishers, Boston, MA1993
• Hematology of Infancy and Childhood. 
  Chapter: The lymphomas and lymphadenopathy. 
  Page 1319 - 1353Link MP and Donaldson SSEditors: D Nathan and F Oski.W. B. Saunders Co., Philadelphia, PA1992
• Nelson self-assessment in pediatrics. A continuing medical education supplement. 
  Chapter: Cases in Hematology/Oncology. 
  Link MPEditors: C Prober and R Behrman.WB Saunders Co., Philadelphia, PA1992
• Comprehensive Textbook of Oncology. 
  Chapter: Childhood lymphomas: Hodgkin's disease and non-Hodgkin's lymphoma. 
  Page 1514 - 1532Donaldson SS and Link MPEditors: SC Schimpff, MC Robson, and AR Moossa.Williams & Wilkins, Baltimore, MDEdition 2nd,1991
• Clinical Pediatric Oncology 
  Chapter: Bone sarcomas. 
  Page 545 - 576Link MP, Grier HE and Donaldson SSEditors: DJ Fernbach and TJ Vietti.Mosby, St. Louis, MOEdition 4th,1991
• Cancer Principles and Practice of Oncology. 
  Chapter: Sarcomas of Bone. 
  Page 585 - 289Malawer MM, Link MP and Donaldson SSEditors: V DeVita, S Hellman and S Rosenberg.J.B. Lippincott, Philadelphia, PAEdition 3rd,1989
• New Directions in Cancer Treatment. 
  Chapter: Osteosarcoma. 
  Page 585 - 589Link MPEditors: Ian Magrath.Springer-Verlag1989
• Principles and Practice of Pediatric Oncology. 
  Chapter: Osteosarcoma. 
  Page 689 - 711Link MP and Eilber FREditors: P Pizzo and D Poplack.J.B. Lippincott, Philadelphia, PA1989
• Recent Concepts in Sarcoma Treatment. Proceedings of the International Symposium on Sarcomas, Tarpon Springs, Florida, October 8-10, 1987. 
  Chapter: Adjuvant chemotherapy in the treatment of osteosarcoma: Results of the Multi-Institutional Osteosarcoma Study. 
  Page 283 - 290Link MP, Shuster JJ, Goorin AM, Miser A, Meyer WH, Kingston JE, Belasco J, Baker AR, Ayala AG and Vietti TEditors: J Ryan and LO Baker.Kluwer Academic Publishers, Dordrecht, The Netherlands1988
• Hodgkin's Disease in Children. 
  Chapter: Clinical investigations of children with Hodgkin's disease at Stanford University Medical Center. A preliminary overview using low-dose irradiation and alternating ABVD/MOPP chemotherapy. 
  Page 307 - 315Donaldson SS, Link MP, McDougall IR, Parker BR and Shochat SJEditors: WA Kamps.Kluwer Academic Publishers, Boston, MA1988
• Comprehensive Textbook of Oncology 
  Chapter: Childhood lymphomas: Hodgkin's disease and non-Hodgkin's lymphoma. 
  Page 1161 - 1178Donaldson SS and Link MPEditors: SC Schimpff, MC Robson, and AR Moossa.Williams & Wilkins, Baltimore, MD1986
• Comprehensive Textbook of Oncology. 
  Chapter: Osteosarcoma. 
  Page 1179 - 1190Link MPEditors: SC Schimpff, MC Robson and AR Moossa.Williams & Wilkins, Baltimore, MD1986
• Folates & Antifolates in Cancer Chemotherapy: New Perspectives. 
  Chapter: High dose methotrexate with leucovorin rescue in the treatment of osteosarcoma. 
  Page 1 - 13Link MPWorld Health Communications, New York, NY1986
• Cancer in Children 
  Chapter: Malignant T-cell and other non-Hodgkin's lymphoma. 
  Page 152 - 163Amylon MD, Link MP and Murphy SBEditors: A. Barrett and PA Voute.Springer-Verlag, LondonEdition 2nd,1986
• Important Advances in Oncology 1986. 
  Chapter: Adjuvant chemotherapy of osteosarcoma. 
  Page 193 - 207Link MPEditors: VT DeVita, S Hellman, SA Rosenberg.J.P. Lippincott, Philadelphia, PA1986
• Pediatr Clin North Am. 
  Chapter: Non-Hodgkin's lymphoma in childhood. 
  Page 699 - 720Link MPEditors: A Altman.WB Saunders, Philadelphia, PA1985
• Monoclonal Antibodies and Functional Cell Lines. 
  Chapter: Monoclonal antibodies to human lymphocytes: Clinical application in the therapy of leukemia. 
  Page 193 - 214Levy R, Stratte P, Link M, Maloney DG, Oseroff A and Miller RAEditors: RH Kennet, TJ McKearn and KB Bechtol.Plenum Publishing Corp., New York, NY1984
• Quo Vadis? Flow Cytometry & Monoclonal Antibodies for Therapy Monitoring. 
  Chapter: Thera¬peutic potential of monoclonal antibodies in leukemias and lymphomas. 
  Page 231 - 238Miller RA, Stratte P, Maloney DG, Oseroff A, Link M and Levy REditors: Gross, FK Jansen, P Poncelet, R Roncucci.Sanofi Recherche, Montpellier, France1984
• Human Tumor Cloning 
  Chapter: Continuous in vitro growth of T-cell acute lymphoblastic leukemia of childhood (T-ALL) in an hypoxic environment. 
  Page 279 - 288Smith SD, Warnke RA, Shatsky M, Link MP, Cohen PS and Glader BEEditors: SE Salmon and JM Trent.Grune & Stratton Inc., New York, NY1984
• Join now to see all

Abstracts/Posters

• Autologous transplantation for Hodgkin disease: A tale of two eras.
  Garfin PM, Luna-Fineman S, Amylon M, Kharbanda S, Weinberg KI, Willert JR, Porteus M, Link M, Agarwal R, Biol Blood Marrow Transplant, 1/1/2013
• Stanford V chemotherapy and involved field radiotherapy for children and adolescents with unfavorable risk Hodgkin lymphoma: Results of a multi-institutional prospect...
  Metzger M, Billett A, Friedmann AM, Krasin MJ, Howard SC, Weinstein HJ, Larson E, Marcus KC, Billups C, Wu J, Donaldson SS, Link MP, Hudson MM, J Clin Oncol, 1/1/2012
• Results of a prospective clinical trial for VAMP alone without irradiation for pediatric favorable, early-stage Hodgkin lymphoma patients who achieve an early complete...
  Metzger M, Weinstein HJ, Hudson MM, Billett A, Larson E, Friedmann AM, Donaldson SS, Krasin MJ, Kun LE, Marcus KC, Yock TI, Tarbell N, Billups C, Wu J, Link MP, J Clin Oncol, 1/1/2011
• Second malignant neoplasms among survivors of pediatric Hodgkin disease treated with low-dose radiation (15-25.5 Gy) and chemotherapy.
  O’Brien MM, Donaldson SS, Whittemore AS, Link MP, J Clin Oncol, 1/1/2009
• End results of a prospective clinical trial with VAMP and low-dose involved-field radiation for pediatric patients with favorable early-stage Hodgkin’s disease.
  Donaldson S, Tarbell N, Weinstein H, Link M, Kun L, Billett A, Marcus K, Hurwitz C, Young J, Brain S, Hudson M, Int J Radiation Oncol Biol Phys, 1/1/2005
• Therapy-related myelodysplasia/leukemia (t MDS/AML) following treatment of children with Ewing sarcoma and primitive neuroectodermal tumor of bone (PNET).
  Bhatia S, Krailo M, Chen Z, Burden L, Dickman P, Grier H, Link M, Meyers P, Perlman E, Robison LL, Miser J, Proc Am Soc Clin Oncol, 1/1/2005
• Favorable treatment outcome of children with early stage large B-cell and anaplastic large cell lymphomas.
  Link MP, Devidas M, Murphy SB, Behm FG, Hutchison R, Proc Am Soc Clin Oncol, 1/1/2004
• Cyclophosphamide dose intensification during induction therapy is feasible but does not appear to improve the outcome of children and adolescents with intermediate ris...
  Spunt SL, Hock LM, Ruymann FB, Qualman SJ, Donaldson SS, Rodeberg DA, Anderson JR, Crist WM, Link MP, Proc Am Soc Clin Oncol, 1/1/2002
• Prognostic factors in pediatric Hodgkin’s disease.
  Smith RS, Chen Q, Hudson M, Link M, Kun L. Tarbell N, Weinstein H, Billett A, Marcus K, Donaldson SS, Int J Radiation Oncol Biol Phys, 1/1/2001
• High dose methotrexate (HDMTX) pharmacokinetics in osteosarcoma.
  Crews KR, Liu T, Rodriguez-Galindo C, Pratt CB, Tan M, Panetta JC, Meyer WH, Link MP, Daw NC, Proc Am Soc Clin Oncol, 1/1/2001
• Addition of ifosfamide and muramyl tripeptide to cisplatin, doxorubicin and high dose methotrexate improves event free survival (EFS) in localized osteosarcoma (OS).
  Meyers P, Schwartz C, Bernstein M, Betcher D, Conrad E, Ferguson W, Gebhardt M, Goodman M, Goorin A, Grier H, Harris M, Healey J, Huvos A, Kleinerman E, Krailo M, Link..., Proc Am Soc Clin Oncol, 1/1/2001
• Comparison of dose intensified and standard dose chemotherapy for the treatment of non-metastatic Ewing’s sarcoma (ES) and primitive neuroectodermal tumor (PNET) of bo...
  Granowetter L, Womer R, Devidas M, Perlman E, Shamberger R, Link M, Neff J, Marcus K, Sailer S, Goorin A, Arndt C, Dickman P, Gebhardt M, Grier H, Med Pediatr Oncol; XXXIIIrd Annual Meeting of SIOP, Brisbane, Australia, 1/1/2001
• Cyclosporine A (CSA) to overcome multiple drug resistance in osteogenic sarcoma (OS): A Pediatric Oncology Group study (POG 9357).
  Schwartz CL, Bernstein M, Teot L, Devidas M, Link M, Med Pediatr Oncol; XXXIIIrd Annual Meeting of SIOP, Brisbane, Australia, 1/1/2001
• Group sequential design of case-control studies for pediatric acute lymphoblastic leukemia cell banks.
  Shuster J, Link M, Camitta B, Pullen J, Behm F, International Society for Clinical Biostatistics, Trent, Italy, 9/4/2000
• What constitutes optimal therapy for rhabdomyosarcoma (RMS) of the female genitourinary tract?
  Arndt C, Donaldson S, Andrassy R, Anderson J, Laurie F, Link M, Raney RB, Maurer H, Crist W for the Intergroup Rhabdomyosarcoma Study Group (IRSG), Med Pediatr Oncol; Annual Meeting of SIOP, Amsterdam, 1/1/2000
• ALK-negative cutaneous anaplastic large cell lymphoma (ALCL) in children frequently relapses.
  Vajpayee N, Kepner J, Link MP, Laver J, Murphy S, Desai S, Schwenn M, Tarbell N, Fitzgerald TJ, Hutchison RE, Blood, 1/1/2000
• Bone marrow stroma-supported recovery of T-lineage acute lymphoblastic leukemia (T-ALL) cells is prognostic of treatment outcome: A Pediatric Oncology Group study.
  Winter SS, Sweatman JJ, Shuster JJ, Amylon MD, Link MP, Larson RS, Blood, 1/1/2000
• Which patients with rhabdomyosarcoma (Rms) and microscopic residual tumor (group II) fail therapy? A report from the Intergroup Rhabdomyosarcoma Study Group (Irsg).
  Smith LM, Anderson JR, Qualman SJ, Crist WM, Paidas CN, Pappo AS, Link MP, Grier HE, Wiener ES, Breneman JC, Raney RB, Donaldson SS, Proc Am Soc Clin Oncol, 1/1/2000
• Burkitt-like lymphoma is immunophenotypically different from Burkitt lymphoma in young persons.
  Hutchison RE, Finch C, Kepner J, Fuller C, Bowman P, Link M, Schwenn M, Laver J, Desai S, Barrett D, Murphy SB, Seventh International Conference on Malignant Lymphoma, Lugano, 6/2/1999
• Children from ethnic minorities have benefited equally as other children from contemporary therapy for rhabdomyosarcoma (RMS): A report from the Intergroup Rhabdomyos...
  Crist W, Anderson J, Lobe T, Wharam M, Qualman S, Raney RB, Ruymann F, Womer RB, Meyer W, Link M, J Pediatr Hematol Oncol, 1/1/1999
• Phase I trial of pegylated liposomal doxorubicin (DOXIL) in children with solid tumors.
  Harney E, Cochrane D, Marina N, Bernstein M, Link MP, Proc Am Soc Clin Oncol, 1/1/1999
• Effects of cranial radiation in children with high risk T-cell acute lymphoblastic leukemia: A Pedatric Oncology Group report.
  Laver JH, Barredo JC, Amylon M, Kurtzberg J, Camitta BM, Pullen J, Link M, Ravindranath Y, Murphy SB, Shuster, J, Proc Am Soc Clin Oncol, 1/1/1999
• Efficacy of ifosfamide (IFOS) and doxorubicin (DOX) given as a phase II “window” in children with newly diagnosed metastatic rhabdomyosarcoma (RMS): A report from the...
  Sandler E, Lyden E, Ruymann F, Maurer H, Wharam M, Parham D, Link M, Crist W, Proc Am Soc Clin Oncol, 1/1/1999
• Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13): Favorable prognosis in T-Cell Cases.
  Rubnitz JE, Camitta BM, Raimondi SC, Carroll AJ, Borowitz MJ, Shuster JJ, Link MP, Pullen DJ, Downing JR, Behm FG, Mahmoud H, Pui C-H, Blood, 1/1/1998
• Successful phase II trial of etoposide and high dose ifosfamide in newly diagnosed metastatic osteosarcoma: An update. A Pediatric Oncology Group trial (POG).
  Goorin AM, Gieser P, Ferguson W, Harris M, Link M, Gebhardt M, Siegal GP, Shamberger RC, Bernstein M, Schwartz C, Berrey H, Grier, HE, Med Pediatr Oncol; XXXth Annual Meeting of SIOP, Yokohama, Japan, 1/1/1998
• Join now to see all

Lectures

• Progress Against Cancer: The Lessons from Our Children. 
  Petach Tikva, Israel - 6/26/2014
• Childhood Hodgkin Lymphoma: Studies from Stanford and the Pediatric Hodgkin Consortium. (Visiting Professor) 
  Schneider Children’s Medical Center of Israel and Tel Aviv University, Petach Tikva, Israel - 6/25/2014
• Are T-lymphoblastic leukemia and T-lymphoblastic lymphoma the same disease entity? Are their current definitions appropriate? 
  Chicago, IL - 3/31/2014
• Ethical Dilemmas in the Face of Shortages of Essential Medicines. 
  Boston, MA - 10/21/2013
• Causes and Effects of the Shortage of Oncology Drugs: Lessons and Solutions for Children Globally. 
  Dana Farber Cancer Institute Cancer and Blood Disorders Center, Boston, MA - 5/23/2013
• "Progress Against Cancer: The Lessons from Our Children." 
  The MD Anderson Cancer Center, Houston, TX - 4/4/2013
• Pediatric Oncology 
  MD Anderson Hospital - 4/1/2013
• Educational Program Session: “Clinical Genomics for the Pediatric Hematologist/Oncologist”—Session Moderator. 
  Miami, FL - 4/1/2013
• Progress Against Cancer: The Lessons from Our Children (Visiting Professor) 
  McMaster University, Juravinsky Cancer Centre and Department of Pediatrics. Hamilton, Ontario, Can - 11/28/2012
• Challenges in Pediatric Cancer Advocacy. Case Study: Drug Shortages and Children with Cancer. The Children’s Cause. 
  10/1/2012
• Webinar: Where Are My Meds? Managing Risk in the Healthcare Supply Chain. 
  Stanford, CA - 7/20/2012
• Adult Survivors of Childhood Cancer 
  Stanford, CA - 6/9/2012
• Presidential Address. “Collaborating to Conquer Cancer: Lessons from our Children.” 
  Chicago, IL - 6/1/2012
• Lessons from Our Children: Implications of What We Have Learned (Session chair and speaker) 
  Chicago, IL - 4/1/2012
• Pediatric Cancer in the Age of Genomics—Lessons from our Children. 
  Chicago, IL - 4/1/2012
• The Oncology Drug Shortage: A Crisis in Care. 
  Washington, DC - 3/22/2012
• Keynote Address: “Three Decades of Research in the Non-Hodgkin Lymphomas of Childhood: Progress and Prospects.” 
  Auckland, New Zealand - 10/28/2011
• "Improving the Quality of Delivered Cancer Care: Are There Lessons From Our Children?" 
  Stockholm, Sweden - 9/23/2011
• Visiting Professor and Keynote Speaker 
  Einstein College Of Medicine and The Children’s Hospital at Montefiore. NY - 4/16/2011
• Visiting Professor and Keynote Speaker for Pediatric Research Day 
  Einstein College of Medicine and the Children’s Hospital at Montefiore - 4/1/2011
• Lessons Learned from the Non-Hodgkin Lymphomas of Childhood. 
  Children’s Hospital of Michigan, Detroit, MI - 8/5/2010
• Educational Session: “Medical, Regulatory, and Ethical Ambiguity in Off-Protocol Use of New Agents for Childhood Cancer: MTP-PE as an Example”—Session Chairman. 
  Chicago, IL - 5/1/2009
• Lessons Learned from the Non-Hodgkin Lymphomas of Childhood. (Brent Eley Visiting Professor in Pediatric Oncology) 
  University of Colorado Cancer Center and The Childrens Hospital, Denver, CO - 3/5/2009
• Three Decades of Research on Therapy for Osteosarcoma: Known Knowns, Known Unknowns, and Unknown Unknowns (Brent Eley Visiting Professor in Pediatric Oncology) 
  University of Colorado Cancer Center and The Childrens Hospital, Denver, CO - 3/5/2009
• Educational Program Session: “Fundamentals of Clincal Trial Design and Methodology”—Session Chairman. 
  Chicago, IL - 5/1/2008
• Join now to see all